0,932  0,004  CYP1A2 substrate
0,896  0,002  UGT1A9 substrate
0,879  0,003  NOS2 expression inhibitor
0,869  0,005  TNF expression inhibitor
0,856  0,004  Chemoprotective
0,840  0,002  UGT1A3 substrate
0,830  0,007  Caspase 9 stimulant
0,813  0,002  SULT1A3 substrate
0,812  0,003  UGT1A1 substrate
0,813  0,004  UDP-glucuronosyltransferase substrate
0,813  0,004  Antioxidant
0,812  0,003  Skin whitener
0,806  0,004  UGT1A6 substrate
0,794  0,003  Antimutagenic
0,804  0,016  Apoptosis agonist
0,781  0,005  CYP2C19 substrate
0,774  0,005  Aldehyde oxidase inhibitor
0,767  0,004  Free radical scavenger
0,767  0,004  Caspase 3 stimulant
0,763  0,004  Genotoxic
0,762  0,008  Antihypercholesterolemic
0,753  0,002  UGT2B15 substrate
0,755  0,005  CTGF expression inhibitor
0,755  0,022  Antiinflammatory
0,732  0,005  Amyloid beta aggregation inhibitor
0,722  0,003  Melanin inhibitor
0,714  0,003  Amylase inhibitor
0,719  0,009  Chemopreventive
0,704  0,004  Monophenol monooxygenase inhibitor
0,703  0,003  Estrogen receptor beta antagonist
0,701  0,005  Histamine release inhibitor
0,700  0,005  AR expression inhibitor
0,695  0,005  CYP1A2 inhibitor
0,692  0,002  Cystathionine beta-synthase inhibitor
0,685  0,003  Estrogen antagonist
0,675  0,001  Histidine decarboxylase inhibitor
0,700  0,034  Alpha-glucosidase inhibitor
0,664  0,001  Creatine kinase inhibitor
0,670  0,024  Antineoplastic (breast cancer)
0,669  0,024  Transcription factor NF kappa B inhibitor
0,639  0,005  GABA C receptor rho-3 antagonist
0,650  0,023  CYP3A4 substrate
0,628  0,003  Estrogen receptor alpha antagonist
0,627  0,002  Antihemorrhagic
0,630  0,010  Proliferative diseases treatment
0,638  0,021  Antidiabetic
0,638  0,021  Cyclophilin D inhibitor
0,622  0,009  NOS3 expression inhibitor
0,618  0,008  CYP2C19 inhibitor
0,621  0,021  15-Lipoxygenase inhibitor
0,601  0,005  MAO inhibitor
0,601  0,004  Peroxidase inhibitor
0,600  0,004  Sulfotransferase substrate
0,599  0,008  Hypoglycemic
0,599  0,010  Cardioprotectant
0,592  0,012  Hepatic disorders treatment
0,584  0,005  Antihypertriglyceridemic
0,586  0,009  Antiamyloidogenic
0,581  0,007  Vascular (periferal) disease treatment
0,584  0,011  Lipoxygenase inhibitor
0,583  0,011  Nitric oxide antagonist
0,582  0,012  Apoptosis antagonist
0,583  0,015  Mutagenic
0,577  0,012  Antiosteoporotic
0,565  0,006  Antihypoxic
0,557  0,003  GST M1-1 substrate
0,552  0,003  Beta glucuronidase inhibitor
0,564  0,018  Sensitization
0,558  0,013  Antineoplastic (brain cancer)
0,560  0,018  Bone diseases treatment
0,545  0,004  VCAM1 expression inhibitor
0,550  0,010  Hypoxia-inducible factor 1 alpha inhibitor
0,559  0,020  Carcinogenic
0,555  0,017  Spasmolytic
0,538  0,002  Estrogen receptor beta agonist
0,551  0,016  Cytostatic
0,532  0,004  Xanthine oxidase inhibitor
0,531  0,004  Breast cancer-resistant protein inhibitor
0,530  0,006  Hepatoprotectant
0,526  0,003  Estrogen agonist
0,526  0,004  5 Hydroxytryptamine uptake stimulant
0,540  0,036  Alzheimer's disease treatment
0,526  0,025  Respiratory analeptic
0,525  0,028  Prostate cancer treatment
0,493  0,004  Antitussive
0,493  0,005  MAO B inhibitor
0,496  0,012  Antineoplastic enhancer
0,497  0,012  Vasodilator
0,517  0,036  Antibacterial
0,483  0,005  NOS3 expression enhancer
0,500  0,022  Analeptic
0,491  0,016  Antipyretic
0,513  0,037  Antileukemic
0,491  0,020  Antineoplastic (glioma)
0,470  0,005  Glutathione S-transferase substrate
0,469  0,004  Aromatase inhibitor
0,491  0,027  CYP2C9 inhibitor
0,490  0,026  Cytotoxic
0,467  0,005  Acetylcholinesterase inhibitor
0,498  0,036  Antineoplastic (colorectal cancer)
0,458  0,003  NAD(P)H dehydrogenase (quinone) inhibitor
0,457  0,004  Neurotrophic factor enhancer
0,471  0,026  Antineoplastic (cervical cancer)
0,476  0,037  Antineoplastic (colon cancer)
0,457  0,019  Tumour necrosis factor alpha release inhibitor
0,443  0,006  Pneumotoxic
0,470  0,036  Teratogen
0,441  0,008  Lipid peroxidase inhibitor
0,477  0,046  GST A substrate
0,465  0,033  5 Hydroxytryptamine release stimulant
0,454  0,031  Antifungal
0,464  0,045  5 Hydroxytryptamine release inhibitor
0,442  0,025  ICAM1 expression inhibitor
0,436  0,019  Antidiabetic symptomatic
0,437  0,023  UGT2B4 substrate
0,435  0,021  Antiparasitic
0,463  0,051  Antineoplastic (lung cancer)
0,456  0,046  CYP2C9 substrate
0,457  0,047  Antipruritic, allergic
0,403  0,004  Carbonic anhydrase III inhibitor
0,407  0,009  Cholinergic
0,412  0,015  P-glycoprotein inhibitor
0,405  0,011  Antihypotensive
0,408  0,014  UGT1A4 substrate
0,400  0,009  Protein-tyrosine phosphatase inhibitor
0,401  0,016  Antihelmintic
0,410  0,026  Antineoplastic (glioblastoma multiforme)
0,401  0,018  RNA-directed DNA polymerase inhibitor
0,387  0,006  UGT2B1 substrate
0,402  0,022  Myocardial infarction treatment
0,384  0,005  Cholesterol synthesis inhibitor
0,412  0,036  12-Lipoxygenase inhibitor
0,414  0,040  Embryotoxic
0,378  0,011  Topoisomerase II inhibitor
0,365  0,004  Postmenopausal disorders treatment
0,402  0,043  CYP2D6 substrate
0,390  0,032  Antiprotozoal (Leishmania)
0,395  0,039  Antineoplastic (pancreatic cancer)
0,361  0,007  Protein-tyrosine phosphatase 1B inhibitor
0,350  0,006  Expectorant
0,356  0,017  UGT2B7 substrate
0,344  0,005  Topoisomerase II alpha inhibitor
0,382  0,044  Antineoplastic (melanoma)
0,342  0,005  Nitric-oxide synthase stimulant
0,395  0,058  Stroke treatment
0,340  0,005  Carbonic anhydrase XV inhibitor
0,337  0,003  Estrogen receptor alpha agonist
0,353  0,024  Antineoplastic (sarcoma)
0,373  0,046  Radioprotector
0,391  0,063  Ulceration
0,362  0,036  Cardiovascular analeptic
0,363  0,037  DNA damaging
0,338  0,012  MAO A inhibitor
0,327  0,004  Gastritis treatment
0,354  0,031  Psychostimulant
0,344  0,022  Dual specificity phosphatase inhibitor
0,335  0,013  Protein kinase stimulant
0,351  0,029  Antiulcerative
0,342  0,022  Dual specificity phosphatase 3 inhibitor
0,354  0,036  Antineoplastic (osteosarcoma)
0,322  0,004  Mucolytic
0,326  0,009  NADPH oxidase inhibitor
0,334  0,024  Platelet adhesion inhibitor
0,311  0,004  VEGF expression inhibitor
0,340  0,037  Antineoplastic (liver cancer)
0,307  0,006  Dementia treatment
0,313  0,015  Diabetic nephropathy treatment
0,304  0,006  Carbonic anhydrase VI inhibitor
0,306  0,009  Antiprotozoal (Coccidial)
0,353  0,056  Antineoplastic (ovarian cancer)
0,302  0,007  Vascular dementia treatment
0,299  0,004  Antiviral (Coronavirus)
0,299  0,004  Antiviral (SARS coronavirus)
0,305  0,010  5-Lipoxygenase inhibitor
0,308  0,014  Antidote
0,311  0,020  Antineoplastic (squamous cell carcinoma)
0,311  0,020  Glyceraldehyde-3-phosphate dehydrogenase inhibitor
0,295  0,005  SULT1A1 substrate
0,298  0,012  Alkaline phosphatase inhibitor
0,299  0,013  Antidiarrheal
0,287  0,003  Ca(v)3.2 blocker
0,293  0,009  Interleukin 4 antagonist
0,296  0,013  Alkylator
0,309  0,027  Gastrin inhibitor
0,295  0,015  Cyclooxygenase 1 inhibitor
0,287  0,006  GABA C receptor rho-2 antagonist
0,305  0,029  Antiviral (Influenza)
0,281  0,008  Androgen antagonist
0,275  0,004  Carbonic anhydrase VII inhibitor
0,320  0,051  Antineoplastic (non-small cell lung cancer)
0,268  0,004  Multidrug resistance-associated protein 1 inhibitor
0,326  0,069  Streptokinase A inhibitor
0,259  0,004  SULT1E1 substrate
0,317  0,062  Lipoprotein disorders treatment
0,271  0,017  M18 aspartyl aminopeptidase inhibitor
0,269  0,016  UGT2B9 substrate
0,305  0,053  Transcription factor STAT inhibitor
0,265  0,014  Chelator
0,268  0,020  Interleukin 6 antagonist
0,269  0,022  Liver fibrosis treatment
0,305  0,059  Antineurogenic pain
0,268  0,025  Carcinogenic, group 3
0,355  0,113  Calcium channel L-type activator
0,317  0,078  Antithrombotic
0,282  0,043  Tyrosine 3 hydroxylase inhibitor
0,242  0,007  GABA C receptor antagonist
0,331  0,097  Immunosuppressant
0,240  0,005  Antineoplastic (uterine cancer)
0,311  0,079  Vasodilator, coronary
0,288  0,055  Superoxide dismutase inhibitor
0,237  0,005  Aldose reductase inhibitor
0,237  0,005  Papain-like protease (SARS coronavirus) inhibitor
0,252  0,022  Succinate dehydrogenase inhibitor
0,249  0,021  LDLR expression enhancer
0,303  0,076  CYP3A4 inhibitor
0,248  0,021  Heat shock protein 90 antagonist
0,339  0,113  Antiparkinsonian
0,230  0,008  Opioid kappa receptor antagonist
0,225  0,004  Ca(v)3.1 blocker
0,225  0,004  Estradiol 17 beta-dehydrogenase inhibitor
0,224  0,004  DOPA decarboxylase inhibitor
0,273  0,053  Cyclic AMP phosphodiesterase inhibitor
0,237  0,020  Aldehyde dehydrogenase inhibitor
0,226  0,011  CF transmembrane conductance regulator agonist
0,267  0,054  Antimitotic
0,321  0,108  Atherosclerosis treatment
0,214  0,004  Ornithine decarboxylase inhibitor
0,226  0,017  Carcinogenic, group 2B
0,229  0,020  Topoisomerase I inhibitor
0,218  0,009  AMP-activated protein kinase stimulant
0,215  0,008  Antiviral (Influenza B)
0,279  0,073  Antidiabetic (type 2)
0,240  0,035  Antihelmintic (Nematodes)
0,209  0,007  GABA C receptor rho-1 antagonist
0,248  0,046  Antialcoholic
0,265  0,063  Angiogenesis stimulant
0,259  0,058  Interleukin antagonist
0,240  0,040  Insulin sensitizer
0,211  0,012  Antihelmintic (Trematoda)
0,201  0,004  Xanthine dehydrogenase inhibitor
0,290  0,094  FMO1 substrate
0,219  0,025  Antifungal enhancer
0,206  0,012  HDL-cholesterol increasing
0,206  0,012  Uric acid excretion stimulant
0,209  0,016  Cyclooxygenase 3 inhibitor
0,206  0,013  Carbonic anhydrase XIII inhibitor
0,264  0,073  Transcription factor STAT3 inhibitor
0,196  0,006  Lipase inhibitor
0,235  0,045  CYP2B6 inhibitor
0,214  0,024  DNA polymerase I inhibitor
0,259  0,070  Antineoplastic (bladder cancer)
0,193  0,004  3-Oxoacyl-[acyl-carrier-protein] synthase inhibitor
0,213  0,025  Antirickettsial
0,207  0,020  Antineoplastic antibiotic
0,218  0,035  Antiviral (Influenza A)
0,215  0,033  Tubulin antagonist
0,234  0,053  Abortion inducer
0,220  0,040  Antiviral (Herpes)
0,225  0,046  Antipruritic, non-allergic
0,215  0,036  Cyclooxygenase inhibitor
0,222  0,044  Amyloid beta precursor protein antagonist
0,210  0,036  Toxic, respiratory center
0,210  0,037  Phospholipase A2 inhibitor
0,177  0,004  Fatty acid synthase inhibitor
0,266  0,094  Antiischemic
0,212  0,040  Antineoplastic (carcinoma)
0,208  0,038  Interferon gamma antagonist
0,185  0,016  Photosensitizer
0,264  0,098  Antimycobacterial
0,186  0,024  Butyrylcholinesterase inhibitor
0,174  0,012  Electron transport complex I inhibitor
0,185  0,024  Microtubule formation inhibitor
0,190  0,029  Proteasome inhibitor
0,198  0,038  UGT2B10 substrate
0,161  0,005  Opioid kappa receptor agonist
0,186  0,030  Gout treatment
0,158  0,005  Antiviral (Hepatitis A)
0,169  0,021  Opioid antagonist
0,189  0,041  Carcinogenic, group 1
0,159  0,012  Paget's disease treatment
0,151  0,005  Neuraminidase inhibitor
0,183  0,038  Cell wall synthesis inhibitor
0,243  0,099  Immunostimulant
0,201  0,059  Antiviral (Hepatitis)
0,142  0,003  Estradiol 17 beta-dehydrogenase 1 inhibitor
0,161  0,023  Ca2+-transporting ATPase inhibitor
0,219  0,082  Cardiodepressant
0,155  0,020  Urease inhibitor
0,184  0,050  Arachidonic acid antagonist
0,234  0,101  Antituberculosic
0,159  0,027  Constipation treatment
0,200  0,069  DNA methyltransferase I inhibitor
0,141  0,010  Alpha tubulin antagonist
0,188  0,057  Heat shock protein 90 alpha antagonist
0,150  0,022  Prolactin inhibitor
0,170  0,042  Cyclooxygenase 2 inhibitor
0,222  0,095  Antineoplastic (renal cancer)
0,181  0,054  Cystic fibrosis treatment
0,141  0,018  Macrophage migration inhibitory factor inhibitor
0,144  0,021  Anabolic
0,144  0,022  Alcohol dehydrogenase inhibitor
0,183  0,062  Antipruritic
0,140  0,020  UGT2B11 substrate
0,236  0,117  FMO3 substrate
0,135  0,016  HIV-1 integrase (3'-Processing) inhibitor
0,183  0,065  Mcl-1 antagonist
0,143  0,025  Toll-Like receptor 4 antagonist
0,247  0,129  Vasodilator, peripheral
0,151  0,033  Contraceptive female
0,147  0,030  UDP-glucose 4-epimerase inhibitor
0,220  0,103  Antiprotozoal (Trypanosoma)
0,173  0,056  Hair growth stimulant
0,140  0,024  Actinic keratosis treatment
0,153  0,039  Heat shock protein 70 antagonist
0,204  0,091  Hypolipemic
0,132  0,020  Interleukin 12 antagonist
0,128  0,019  Keratolytic
0,134  0,025  Protein kinase C zeta inhibitor
0,120  0,012  Neuraminidase (influenza) inhibitor
0,250  0,141  Antineoplastic (small cell lung cancer)
0,158  0,050  Antiseptic
0,158  0,050  Adenylate cyclase stimulant
0,171  0,064  Eye irritation, high
0,148  0,042  Beta amyloid protein antagonist
0,125  0,021  Analgesic, opioid
0,118  0,014  SULT1A2 substrate
0,156  0,052  Alpha-N-acetylglucosaminidase inhibitor
0,118  0,014  D-Ala-D-Ala ligase inhibitor
0,116  0,014  Narcotic antagonist
0,140  0,038  GST P1-1 substrate
0,145  0,044  Coagulant
0,156  0,055  Bone formation stimulant
0,130  0,029  GST T1-1 substrate
0,162  0,063  Insulin secretagoues
0,174  0,075  Antineoplastic (gastric cancer)
0,110  0,012  Opioid agonist
0,103  0,005  Postcoital contraceptive
0,112  0,014  Protein kinase C eta inhibitor
0,200  0,103  MAP-kinase-activated kinase 5 inhibitor
0,160  0,064  Antiischemic, cerebral
0,166  0,070  Antiviral (Hepatitis C)
0,101  0,006  Transcription factor RelA inhibitor
0,162  0,070  Uterine stimulant
0,209  0,117  Flavin-containing monooxygenase substrate
0,118  0,026  Opioid delta receptor antagonist
0,114  0,023  Glutamate decarboxylase inhibitor
0,113  0,023  Carbonic anhydrase V inhibitor
0,111  0,021  Carbonic anhydrase VA inhibitor
0,107  0,019  Leukotriene antagonist
0,181  0,092  DNA methylase inhibitor
0,104  0,015  Carbonic anhydrase VB inhibitor
0,107  0,020  HIV-1 integrase (Strand Transfer) inhibitor
0,114  0,028  Interleukin 5 antagonist
0,203  0,118  DNA synthesis inhibitor
0,109  0,025  Cyclin B3 inhibitor
0,100  0,016  Antidote, heavy metal
0,122  0,038  HIV-1 integrase (Overall Integration) inhibitor
0,175  0,091  Non-steroidal antiinflammatory agent
0,118  0,035  Carcinogenic, group 2A
0,181  0,098  Antiviral (Ebola)
0,148  0,066  Mannose-6-phosphate isomerase inhibitor
0,177  0,095  Pyruvate kinase inhibitor
0,122  0,040  Protein kinase C mu inhibitor
0,099  0,018  Alcohol oxidase inhibitor
0,264  0,183  DNA directed DNA polymerase inhibitor
0,143  0,063  Psychosexual dysfunction treatment
0,163  0,084  Tumour necrosis factor antagonist
0,127  0,048  Choleretic
0,106  0,027  Na+ K+ transporting ATPase inhibitor
0,162  0,084  Phospholipase C inhibitor
0,245  0,168  Antiprotozoal
0,188  0,111  Platelet antagonist
0,133  0,056  Growth stimulant
0,086  0,009  Glucose-6-phosphate translocase inhibitor
0,106  0,030  Opioid mu receptor antagonist
0,148  0,073  Acaricide
0,120  0,045  Bronchodilator
0,082  0,008  Sodium/calcium exchanger inhibitor
0,125  0,051  Excitatory amino acid transporter EAAC1 inhibitor
0,125  0,055  DNA intercalator
0,087  0,017  SULT2A1 substrate
0,096  0,027  HIV-1 integrase inhibitor
0,132  0,064  Antihyperlipoproteinemic
0,073  0,009  Retinoid X alpha receptor agonist
0,202  0,138  Radiosensitizer
0,084  0,023  Glutamate (mGluR7) antagonist
0,129  0,068  Antibacterial (Helicobacter pylori)
0,089  0,029  Glucagon-like peptide 1 agonist
0,064  0,004  Estrogen-related receptor beta antagonist
0,115  0,056  Protein kinase C gamma inhibitor
0,076  0,019  Opioid mu receptor agonist
0,086  0,029  Secretase beta inhibitor
0,103  0,046  ABCA1 expression enhancer
0,087  0,030  Dopamine D1 antagonist
0,146  0,091  Prostatic (benign) hyperplasia treatment
0,211  0,155  Cholesterol antagonist
0,092  0,037  Thioredoxin reductase inhibitor
0,064  0,009  Arginase inhibitor
0,058  0,005  Sodium/glucose cotransporter 2 inhibitor
0,101  0,048  Antiviral (Rhinovirus)
0,058  0,005  ATP citrate lysase inhibitor
0,063  0,011  Neuraminidase (Influenza A) inhibitor
0,101  0,049  Phosphodiesterase 6D inhibitor
0,159  0,107  Antiarrhythmic
0,088  0,036  Histone deacetylase SIRT1 stimulant
0,088  0,036  Histone deacetylase stimulant
0,110  0,059  Mediator release inhibitor
0,070  0,019  Leukotriene B4 antagonist
0,145  0,095  Prostate disorders treatment
0,128  0,078  Contraceptive
0,071  0,021  3(or 17)beta-hydroxysteroid dehydrogenase inhibitor
0,097  0,047  NADH dehydrogenase inhibitor
0,089  0,040  Antibiotic
0,123  0,075  Toll-Like receptor 2 antagonist
0,243  0,197  DNA polymerase beta inhibitor
0,093  0,047  Antispirochetal
0,079  0,034  Anticholelithogenic
0,058  0,013  Dopamine D5 agonist
0,106  0,061  GABA C receptor agonist
0,083  0,039  MAP kinase kinase 7 inhibitor
0,082  0,038  Antitreponemal
0,088  0,045  Glycine receptor antagonist
0,048  0,005  Sodium/glucose cotransporter inhibitor
0,083  0,040  Phosphofructokinase-1 inhibitor
0,114  0,071  Transcription factor STAT6 inhibitor
0,057  0,015  Retinoid X receptor agonist
0,096  0,054  Thioredoxin inhibitor
0,128  0,086  Farnesoid X receptor antagonist
0,073  0,031  MDM2 inhibitor
0,133  0,091  Hemostatic
0,102  0,061  Chronic obstructive bronchitis treatment
0,050  0,010  Cholesterol absorption inhibitor
0,165  0,125  Aryl hydrocarbon receptor agonist
0,076  0,037  Protein kinase C beta inhibitor
0,082  0,043  Telomerase inhibitor
0,048  0,009  Tubulin agonist
0,058  0,020  Carbonic anhydrase IV inhibitor
0,152  0,114  Antieczematic atopic
0,106  0,068  Skin irritative effect
0,089  0,051  Myeloperoxidase inhibitor
0,059  0,022  Squalene epoxidase inhibitor
0,049  0,012  Glucose-6-phosphate dehydrogenase inhibitor
0,091  0,055  Antidote, mercury
0,130  0,094  MAP3K9 inhibitor
0,040  0,005  Sodium/glucose cotransporter 1 inhibitor
0,056  0,022  Cholesterol esterase inhibitor
0,077  0,043  Glycine receptor agonist
0,081  0,047  Phosphodiesterase 4D inhibitor
0,054  0,021  Leukocyte elastase inhibitor
0,209  0,176  Sodium/bile acid cotransporter inhibitor
0,096  0,064  Sphingomyelinase inhibitor
0,133  0,100  Hexokinase inhibitor
0,201  0,169  Angiogenesis inhibitor
0,048  0,016  Estradiol 17 beta-dehydrogenase 2 inhibitor
0,061  0,029  Acetyl-CoA transferase 2 inhibitor
0,067  0,036  Beta tubulin antagonist
0,115  0,083  DNA repair enzyme inhibitor
0,055  0,026  Topoisomerase II beta inhibitor
0,145  0,116  Neurotensin receptor agonist
0,172  0,144  Peptidyltransferase inhibitor
0,133  0,105  MAP kinase kinase 4 inhibitor
0,112  0,086  Antifungal (Pneumocystis)
0,131  0,105  Neuropathy treatment
0,083  0,057  Inducible nitric-oxide synthase inhibitor
0,058  0,034  Leukotriene C antagonist
0,074  0,050  CDC25A inhibitor
0,040  0,016  Sodium-dependent vitamin C transporter 2 inhibitor
0,052  0,029  Antibiotic Glycopeptide-like
0,099  0,076  Antihelmintic (Fasciola)
0,068  0,045  Glutamate (mGluR6) antagonist
0,087  0,065  Triose-phosphate isomerase inhibitor
0,082  0,061  Estrogen-related receptor beta agonist
0,066  0,047  Leukotriene synthesis inhibitor
0,048  0,030  Microtubule stabilization
0,044  0,027  GABA B receptor antagonist
0,043  0,029  DNA gyrase subunit A inhibitor
0,091  0,077  Gastric antisecretory
0,026  0,012  Dopamine D1 agonist
0,062  0,050  Dopamine agonist
0,057  0,045  Heat shock protein 90 beta antagonist
0,047  0,035  Glucose-6-phosphate isomerase inhibitor
0,095  0,083  Endometrios treatment
0,076  0,064  Antidote, organophosphates
0,024  0,013  Estrone sulfatase inhibitor
0,102  0,091  Antiviral (Hepatitis B)
0,035  0,025  Progesterone antagonist
0,064  0,054  Peroxisome proliferator-activated receptor gamma agonist
0,034  0,025  Opioid delta receptor agonist
0,020  0,012  Antibiotic Anthracycline-like
0,048  0,040  Carbonic anhydrase XII inhibitor
0,124  0,116  Antifungal (Cryptococcus)
0,024  0,017  Protein 30S ribosomal subunit inhibitor
0,041  0,034  Dopamine D2 agonist
0,151  0,144  Antineoplastic (lymphoma)
0,035  0,029  Kinesin-like protein 1 inhibitor
0,035  0,029  Kinesin antagonist
0,067  0,061  Glutamate dehydrogenase inhibitor
0,057  0,052  Antimycoplasmal
0,110  0,105  Antiprotozoal (Trichomonas)
0,034  0,029  5-Alpha-reductase inhibitor
0,135  0,131  Anesthetic general
0,030  0,027  Catechol O-methyltransferase inhibitor
0,051  0,048  Dihydroorotate oxidase inhibitor
0,037  0,034  Leukotriene C4 antagonist
0,053  0,051  Androgen agonist
0,107  0,105  Cocaine dependence treatment
0,014  0,012  NMDA receptor phencyclidine site antagonist
0,036  0,034  Retinoic acid alpha receptor agonist
0,096  0,095  TRPA1 agonist
0,101  0,100  Shock treatment
0,021  0,019  Prostaglandin F2 alpha agonist
0,058  0,058  Aryl hydrocarbon receptor antagonist
0,028  0,028  Nucleoside transporters inhibitor

